Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0034 | 1 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0027 | 1 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |